Overview ARQ 197 for Participants With Relapsed or Refractory Germ Cell Tumors Status: Terminated Trial end date: 2011-11-30 Target enrollment: Participant gender: Summary This is a multicenter, single-arm study for safety and efficacy. Phase: Phase 2 Details Lead Sponsor: Daiichi Sankyo Inc.Daiichi Sankyo, Inc.